Your browser doesn't support javascript.
loading
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial.
Koch, Elias A T; Petzold, Anne; Wessely, Anja; Dippel, Edgar; Eckstein, Markus; Gesierich, Anja; Gutzmer, Ralf; Hassel, Jessica C; Knorr, Harald; Kreuzberg, Nicole; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Pföhler, Claudia; Rahimi, Farnaz; Schadendorf, Dirk; Schlaak, Max; Thoms, Kai-Martin; Ugurel, Selma; Utikal, Jochen; Weichenthal, Michael; Schuler-Thurner, Beatrice; Berking, Carola; Heppt, Markus V.
Afiliação
  • Koch EAT; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
  • Petzold A; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.
  • Wessely A; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
  • Dippel E; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany.
  • Eckstein M; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
  • Gesierich A; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.
  • Gutzmer R; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
  • Hassel JC; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany.
  • Knorr H; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
  • Kreuzberg N; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.
  • Leiter U; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
  • Loquai C; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany.
  • Meier F; Department of Dermatology, Ludwigshafen Medical Center, 67059, Ludwigshafen, Germany.
  • Meissner M; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.
  • Mohr P; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
  • Pföhler C; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany.
  • Rahimi F; Institute of Pathology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital Würzburg, 97080, Würzburg, Germany.
  • Schlaak M; Skin Cancer Center Minden, Department of Dermatology, Mühlenkreiskliniken AöR, Ruhr University, Bochum Campus Minden, 32423, Minden, Germany.
  • Thoms KM; Skin Cancer Center, Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, 69120, Heidelberg, Germany.
  • Ugurel S; Department of Ophthalmology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
  • Utikal J; Department of Dermatology and Venereology, Skin Cancer Center at the Center of Integrated Oncology (CIO) Köln Bonn, University Hospital of Cologne, 50937, Cologne, Germany.
  • Weichenthal M; Department of Dermatology, Center for Dermatooncology, University Hospital Tübingen, 72056, Tübingen, Germany.
  • Schuler-Thurner B; Department of Dermatology, University Medical Center Mainz, 55131, Mainz, Germany.
  • Berking C; Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases & Department of Dermatology, University Hospital Carl Gustav Carus, 01307, Dresden, Germany.
  • Heppt MV; Department of Dermatology, Venereology and Allergology, Goethe University, 60590, Frankfurt am Main, Germany.
Front Med ; 17(5): 878-888, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37432641
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Inibidores de Checkpoint Imunológico Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Inibidores de Checkpoint Imunológico Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article